Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
about
Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approachesWhole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studiesAssessment of chemotherapy response in non-Hodgkin lymphoma involving the neck utilizing diffusion kurtosis imaging: a preliminary studyPET/MRI for the evaluation of patients with lymphoma: initial observations.Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted ImagingWhole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma.Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease.Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review.Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.PET/MRI for the body imager: abdominal and pelvic oncologic applications.Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.How PET/MR Can Add Value For Children With Cancer.Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumorsStaging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and (18)F-FDG-PET/CT.Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma.Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?Whole-body MRI in patients with lymphoma: collateral findings.Cerebral schistosomiasis: diffusion-weighted imaging helps to differentiate from brain glioma and metastasis.Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations.Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index.Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis.
P2860
Q26865120-D7062BAE-659D-4F0D-AABB-08D70691C383Q27009307-2D43D143-8CA5-4316-8EB9-868FA087442FQ33620670-91394F59-D1C0-4CFB-9FE6-FD99376C972EQ35737190-AC9E341C-0BE3-406E-BFEA-6930CABE585DQ36057936-ED87947B-2D85-4CC1-B582-6873246A12BBQ36159438-38929143-7D1D-459E-A7B9-955D0DCEE1B1Q36564214-093874A4-C3F6-4689-B035-2D6658E944B7Q36787121-27D18739-284C-4B65-8F97-604537088D54Q38078804-A05F79F2-5866-4637-B6E2-3D2953C0EECDQ38153365-461255DB-5122-4FC2-92F1-1E3918BD7780Q38179320-05D166D1-DFD3-4F7A-AA9B-001765E8CDBEQ38389749-73085DCB-E3E3-4C1F-AF85-088C6093D4E8Q38831143-5EE22E2E-B788-4EB9-8AC9-0C43BCBD1AD4Q39427334-46B1AEF5-02B0-4D3C-B2C7-3DDE7CEE2CD3Q39675210-E739D795-3FB5-4E66-9E22-896AFE74A508Q40939245-FD193952-7AF8-4F93-8006-B27CDC2F93EAQ41825428-A21A028C-7F7B-41D5-8AC6-2F53B83224B2Q41831874-9C2897A5-CA14-4EFD-A5FD-CCF7E37BF65BQ42562978-FD64C028-9C1C-4524-9953-A7E638399C08Q46320895-B2C28DCF-3C2C-4BE7-B68E-A2999C7C3919Q46579579-D4180360-1D84-4534-9B76-138DC75610BFQ48198509-683BF496-F579-46F4-B2A4-59EDBE2784A0Q48355676-39BDAB3F-0F68-45F0-9D55-6FF088C4534CQ49623665-03E63AF2-8107-4188-82B6-6A2520E57459Q49978374-622D7330-A761-4931-A5F3-8FFFB994C9AEQ52983083-42667672-2816-425D-B637-9BB1604682A9Q52991094-93522B10-6A78-4311-996B-6E745A543457Q53056812-DDBE104E-93D6-4678-B8D6-362377A4414DQ55333608-11F7A869-DBFD-4557-9089-861954D866B7
P2860
Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@en
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@nl
type
label
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@en
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@nl
prefLabel
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@en
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@nl
P2093
P2860
P356
P1433
P1476
Whole-body diffusion-weighted ...... staging of lymphoma patients.
@en
P2093
Daniel Molin
Goran Abdulqadhr
Gunnar Aström
Hans Hagberg
Madis Suurküla
P2860
P304
P356
10.1258/AR.2010.100246
P407
P577
2011-03-01T00:00:00Z